Compositions with antibacterial and wound healing activity
EP2614087A1
Process for the production of hyaluronic acid in escherichia coli or bacillus megaterium
EP2614088A1
Process for the production of hyaluronic acid in escherichia coli or bacillus subtilis
EP2448606A2
Biological material suitable for the therapy of osteoarthrosis, ligament damage and for the treatment of joint disorders
EP2443156A1
Process for the synthesis of conjugates of glycosaminoglycanes (gag) with biologically active molecules, polymeric conjugates and relative uses thereof
CN102421443A
Sulphated hyaluronic acids as regulator agents of the cytokine activity
WO2010121700A1
Compositions containing hyaluronic acid, sulphated hyaluronic acid, calcium and vitamin d3 for the treatment of osteoarticular and musculoskeletal disorders
ITPD20090246A1
VISCOELASTIC FROSTS LIKE NEW FILLERS
ITPD20090134A1
NEW MEDICATIONS FOR TOPIC USE BASED HYALURONIC ACID SULFATED AS AN ACTIVATING OR INHABITING CITHOCINIC ACTIVITY
BRPI0910570A2
use of bioconjugates and pharmaceutical formulations
EP2200579A2
Antiviral topical formulations in the form of a bio-adhesive gel
KR20100045986A
Adefovir dipivoxil crystalline monohydrate form
WO2009003624A1
Hyaluronic acid derivatives containing groups able to release no
LU91414A2
Hyaluronic acid amides, derivatives thereof and process for their preparation
WO2008031525A1
Hyaluronic acid derivatives obtained via 'click chemistry' crosslinking
EP2021078A1
Sulphated hyaluronic acid for treating degenerative osteoarthritis
